Abnova Taiwan Corp Stock Fundamentals
| 4133 Stock | TWD 29.10 0.05 0.17% |
Abnova Taiwan Corp fundamentals help investors to digest information that contributes to Abnova Taiwan's financial success or failures. It also enables traders to predict the movement of Abnova Stock. The fundamental analysis module provides a way to measure Abnova Taiwan's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Abnova Taiwan stock.
Abnova |
Abnova Taiwan Corp Company Current Valuation Analysis
Abnova Taiwan's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Abnova Taiwan Current Valuation | 2.11 B |
Most of Abnova Taiwan's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Abnova Taiwan Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Abnova Taiwan Corp has a Current Valuation of 2.11 B. This is 85.33% lower than that of the Life Sciences Tools & Services sector and 54.65% lower than that of the Health Care industry. The current valuation for all Taiwan stocks is 87.33% higher than that of the company.
Abnova Taiwan Corp Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Abnova Taiwan's current stock value. Our valuation model uses many indicators to compare Abnova Taiwan value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Abnova Taiwan competition to find correlations between indicators driving Abnova Taiwan's intrinsic value. More Info.Abnova Taiwan Corp is rated fourth in return on equity category among its peers. It also is rated fourth in return on asset category among its peers reporting about 0.45 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Abnova Taiwan Corp is roughly 2.22 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Abnova Taiwan's earnings, one of the primary drivers of an investment's value.Abnova Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Abnova Taiwan's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Abnova Taiwan could also be used in its relative valuation, which is a method of valuing Abnova Taiwan by comparing valuation metrics of similar companies.Abnova Taiwan is currently under evaluation in current valuation category among its peers.
Abnova Fundamentals
| Return On Equity | 0.0505 | |||
| Return On Asset | 0.0227 | |||
| Profit Margin | 0.15 % | |||
| Operating Margin | 0.12 % | |||
| Current Valuation | 2.11 B | |||
| Shares Outstanding | 60.55 M | |||
| Shares Owned By Insiders | 22.37 % | |||
| Shares Owned By Institutions | 0.55 % | |||
| Price To Earning | 64.88 X | |||
| Price To Book | 1.98 X | |||
| Price To Sales | 5.86 X | |||
| Revenue | 451.49 M | |||
| Gross Profit | 197.34 M | |||
| EBITDA | 78.59 M | |||
| Net Income | 28.37 M | |||
| Cash And Equivalents | 171.86 M | |||
| Cash Per Share | 2.84 X | |||
| Total Debt | 18.4 M | |||
| Debt To Equity | 1.50 % | |||
| Current Ratio | 7.87 X | |||
| Book Value Per Share | 20.50 X | |||
| Cash Flow From Operations | 92.88 M | |||
| Earnings Per Share | 1.02 X | |||
| Target Price | 102.08 | |||
| Number Of Employees | 14 | |||
| Beta | 0.42 | |||
| Market Capitalization | 2.3 B | |||
| Total Asset | 1.28 B | |||
| Retained Earnings | 92 M | |||
| Working Capital | 849 M | |||
| Current Asset | 956 M | |||
| Current Liabilities | 107 M | |||
| Z Score | 75.0 | |||
| Annual Yield | 0.01 % | |||
| Five Year Return | 2.32 % | |||
| Net Asset | 1.28 B | |||
| Last Dividend Paid | 0.46 |
About Abnova Taiwan Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Abnova Taiwan Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Abnova Taiwan using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Abnova Taiwan Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Abnova Corporation manufactures and sells various recombinant proteins and antibodies. Abnova Corporation is headquartered in Taipei, Taiwan. ABNOVA CORPORATION operates under Biotechnology classification in Taiwan and is traded on Taiwan Stock Exchange.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Abnova Stock Analysis
When running Abnova Taiwan's price analysis, check to measure Abnova Taiwan's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abnova Taiwan is operating at the current time. Most of Abnova Taiwan's value examination focuses on studying past and present price action to predict the probability of Abnova Taiwan's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Abnova Taiwan's price. Additionally, you may evaluate how the addition of Abnova Taiwan to your portfolios can decrease your overall portfolio volatility.